The nervous system specific isoenzyme of fructose-l , 6-diphosphate aldolase (E.C.4.I.2. 13), aldolase C" has been purified from human brain, and a sensitive radioimmunoassay has been developed for its detection. This assay is also capable of detecting other hybrid isoenzymes containing the C subunit but not the A 4 isoenzyme. A systematic survey of human organs has shown that
immunoreactive aldolase C is present in all human organs but at levels less than 2 %of those found in human brain; especially low levels occur in kidney, skeletal muscle, lung, and thyroid tissue.The presence of aldolase C in other organs apart from nervous tissue is unlikely to be explicable by innervation alone since significant quantities are found in erythrocytes. The high degree of localisation of aldolase C, in nervous tissue makes it a suitable marker for cell damage within the central nervous system. PURIFICATION PROCEDURE Human brain material was obtained within 12 hours post mortem and stored deep-frozen at -20°C. All purification procedures were performed at 4°C. Frozen brain was chopped into small pieces and homogenised with extraction buffer (100 mmol/l potassium phosphate, pH 7,0, containing 12 mmol/l 2-mercaptoethanol and 1 mmol/l EDTA) in a Kenwood blender (2:1 vjw). The homogenate was centrifuged at 20 000 g for 1 hour in a Sorvall centrifuge, and the clear supernatant was pumped at approximately 200 ml/h through a 20 x 4 cm diameter DEAE cellulose column (Whatman DE 52 preswollen) previously equilibrated with the above extraction buffer. The column was then washed with extraction buffer until the A 2so of the eluate fell below 0·1 unit. The eluate was then dialysed against 2 x 30 volumes of deionised water at 4°C and lyophilised before storage at -20°C.
Of the lyophilised product, 2 g (about i of the total extracted from a single brain of wet weight 1500 g) were redissolved in 100 mmol/l potassium phosphate buffer, pH 7'0, containing 10 mmol/l 2-mercapto-114
The tetrameric enzyme fructose-l,6-diphosphate aldolase (E.C.4.1.2.13) occurs in a variety of vertebrate tissues in multiple forms.! Classically, the parental forms of aldolase are represented by aldolase A, present in muscle and most other vertebrate tissues, aldolase B, which is usually confined to liver and kidney, and aldolase C from nervous tissue.' While aldolase C occurs in a variety of vertebrate brains as part of a five-membered Ah ybrid set, the distribution of the C subunit in organs other than nervous tissue shows considerable interspecies variation.' 11 Electrophoretic methods have demonstrated A~hybrid sets in human, monkey, and porcine hearts but not in bovine heart, while A~sets have been found in bovine and porcine spleen but appear to be absent from the corresponding human and monkey organs." In ruminant mammals, birds, amphibians and fish, aldolase C is present in the majority of tissues.s If aldolase C does represent a nervous-system specific protein in the human, then measurements of this isoenzyme in body fluids may provide a clinically useful index of damage to the central nervous system. However, assays based on electrophoresis followed by activity staining or an immunoprecipitation of enzyme activity are dependent on the enzyme protein retaining its catalytic function. A recent report has suggested that at least one nervoussystem specific isoenzyme (creatine kinase, E.C.2.7.3.2) may exist in other tissues in an immunologically active but enzymatically inactive form. 3 We have therefore re-investigated the distribution of aldolase C in human tissues using a sensitive radioimmunoassay.
Material and methods

MOLECULAR WEIGHT ESTIMATION
The molecular weight of the native enzyme in brain 25°C after addition of the enzyme sample. The reaction was carried out in a total volume of 1 ml with cuvettes of path length 1 em using a Unicam SP 800 ultraviolet recording spectrophotometer. This was performed by the method of Davis'' using 5 x 70 mm tube gels containing 7t% acrylamide (w/v). Sodium dodecyl sulphate gel electrophoresis was performed by the method of Weber and Osbomt using either tube gels, as for the disc gel method, or a slab gel apparatus (Raven Scientific Ltd, Haverhill, Suffolk). Gels run under non-denaturing conditions were stained for aldolase activity using a solution containing 1 mmol/l NAD+, 1 mmol/l PDP, 1 mmol/l sodium arsenate, 0·16 mgjml nitroblue tetrazolium, 0·04 mgjml phenazine rnethosulphate, 0·25 IU/mi glyceraldehyde-3-phosphate dehydrogenase (E.C. 1.2.1.12), 0·1 IU/m1 triosephosphate isomerase (E.C.5.3.1.1), and 50 mmol/l Tris/HCl, pH 7'2. After staining for 15--45 minutes at 37°C in darkness the gels were washed and stored in 10 % glycerol solution. No staining associated with activity was seen for any of the purification samples tested when PDP was omitted from the incubation mixture.
Human brain aldolase C, isoenzyme ethanol, and solid ammonium sulphate was added to give a 40 % saturated solution as calculated by the method of Dixon.' After stirring for 20 minutes the precipitate was removed by centrifugation at 20 000 g for 20 minutes in an MSE 18 refrigerated centrifuge, and the supernatant was then made up to 60 % saturation by further addition of solid ammonium sulphate. After stirring for 20 minutes the precipitate was removed once again by centrifugation at 20 000 g for 20 minutes. This precipitate, which contained 95 % of the recoverable aldolase activity, was then redissolved in 50mmol/1 Tris/HC1, pH 7'0, containing 10 mmol/l 2-mercaptoethanol and 1 mmol/l EDTA (buffer A), and traces of ammonium sulphate were removed by passage through a Sephadex G25 gel filtration column (25 x 2·5 em diameter) previously equilibrated with buffer A.
The eluate containing aldolase activity was then applied to a column of cellulose phosphate (Whatman Pll) which had been previously equilibrated with buffer A. The A 280 of the eluate, which contained very little aldolase activity, was allowed to fall below 0'1 unit before bound aldolase was eluted using a 2·5 mmol/Isolution of the substrate fructose 1,6 diphosphate (PDP) in buffer A.
Fractions containing aldolase activity were pooled and concentrated by ultrafiltration using a Sartorius Collodion bag (GMBH, Mannheim) before being transferred to 50 mmol/l Tris/HCl buffer, pH 7'0, containing 10 mmol/l 2-mercaptoethanol (buffer B) by passage through a G25 Sephadex column (25 x 2'5 em diameter). The pooled fractions from this column were then applied to a DEAE cellulose column previously equilibrated with buffer B (8 x 2 em diameter). After application of the sample, the column was washed with 1 column volume of buffer B before elution of the remaining aldolase activity using a linear gradient from 0 to 200 mmol/l NaCl in buffer B. The peak.fractions of aldolase C, activity, with the exception of those in the leading edge, were then pooled and concentrated using a Sartorius Collodion bag before being stored at -20°C. Peak fractions of the other four isoenzymes were also stored at -20°C for use in characterisation of the radioimmunoassay for aldolase C. A flow sheet for the purification procedure is shown in Figure 1 .
ALDOLASE ASSAY
Aldolase activity was assayed by following the decrease in A 340 due to NADH oxidation in a solution containing 1 rnmol/l PDP, 0·25 mmol/l NADH, o·2 IU glycerol-3-phosphate dehydrogenase (E.C.1.1.1.8), 0·1 IU Triosephosphate Isomerase (E.C.5.3.1.1) (Boehringer, Mannheim), and 50 mmol/l Tris/HCl at a pH of 7· 2 and temperature extracts and after purification was estimated by chromatography on a G 150 Sephadex gel filtration column (90 x 2·5 ern diameter). Before application of a sample, the column was equilibrated with SO mmol/l Tris/HC1, pH 7'4, containing 10 mmol/l 2-mercaptoethanol, 1 mmol/l MgC1 2 , and 100 mmolfl KCl. Samples of both purified protein and an extract of brain tissue (produced as described below) were then chromatographed in the same buffer, and the eluted fractions were assayed for both aldolase activity and aldolase C immunoreactivity. A standard curve for molecular weight estimation was constructed by chromatography of samples of bovine serum albumin,horse IgG, ovalbumin, and cytochrome C under the same conditions.
PRODUCTION OF ANTISERUM
Antiserum to human nervous system specific aldolase was produced in sheep by multiple intradermal injections of o· 5-1 mg purified protein preparations emulsified with Freund's complete or incomplete adjuvant. The sheep were initially injected twice, at monthly intervals, with a partially purified preparation of aldolase C 1 in complete adjuvant which contained no other aldolase isoenzymes. A third injection with 1 mg of the purified protein in incomplete adjuvant was given after a further month, and the sheep was bled 10 days later. The resulting antiserum was tested for the presence of antibodies by neutralisation of aldolase activity and by its ability to bind iodinated human aldolase C 1 •
INHIBITION OF ALDOLASE ACTIVITY
100 ILl aliquots of purified aldolase C 1 dissolved in 50 mmol/l Tris/HC1, pH 8,0, and containing approx. 0·4 IU/mI of aldolase activity were mixed with increasing quantities of neat, sheep anti-human, aldolase C 1 antiserum in LP 3 tubes (Luckham, Burgess Hill, Sussex). To a control series of tubes increasing amounts of non-immune serum were added. Each tube was made up to a total volume of 200 ILl using 50 mmol/l Tris/HC1, pH 8'0. After incubation for 18 hours at 4°C, 20 ILl aliquots were removed from each tube and assayed for aldolase activity.
The aldolase activities/ml of the neat immune and non-immune sera were found to be 10% and 6%, respectively, of that in the purified aldolase C 1 preparation used.
RADIOIMM UNOASSAY PROCED URE
Iodination ofhuman aldolase C 1 Of the purified protein 10 ILg were iodinated by the method of Bolton and Hunter? using Nsuccinimidyl-3, 4 hydroxy-5 (l261) iodophenyl propionate (Radiochemical Centre, Amersham), 
Assay procedure
The assay was performed in LP3 tubes; 100 ILl of standard or unknown aldolase C 1 solution was mixed with 100 ILl of sheep antiserum (at a dilution of 1 in 22 000 in single strength veronal (SSV) buffer, pH 8,1, containing 10'3 gil sodium barbitone,S gIl bovine serum albumin (Armour Pharmaceutical Co, Eastbourne, Sussex), 5 gIl NaC1, and 0·1 gIl sodium azide). After incubation for 24 hours at 4°C, 200 ILl of iodinated protein, containing approximately 5000 dprn, were added. After mixing, the tubes were incubated overnight at 4°C, and, in order to precipitate antibody-bound counts, 100 ILl of nonimmune sheep serum, diluted 1 in 300 in SSV, were added to each tube followed by 100 ILl of donk.eyanti-sheep IgG (Guildhay, University of Surrey) diluted 1 in 10 in SSV. After incubation at 4°C for 1 hour, the tubes were centrifuged at 2000 rpm in an MSE Coolspin refrigerated centrifuge for 30 minutes. The-supernatants were then removed and the pellets counted in a Wallac gamma-counter.
PREPARATION OF HUMAN TISSUE EXTRACTS
Specimens of human organs were obtained within 12-24 hours post mortem and immediately frozen at -70°C. Each specimen was then thawed at 4°C overnight and a 20 %homogenate (wIv) in 50 mmol/l, potassium phosphate buffer, pH 7'0, containing 10 mmol/12-mercaptoethanol and 1 mmol/l MgC1 2 using a Willems Polytron homogeniser, was prepared on ice. After centrifugation at 20 000 g for 30 minutes at 4°C samples of the supernatant were subjected to radioimmunoassay for aldolase C as described previously.
Human erythrocyte haemolysates were prepared by mixing 20 ml of a fresh venepuncture sample with 40 ml ice-cold saline and centrifuging at 20 000 g for 30 minutes. The white cell layer was then removed with a pipette, and the packed red cells were washed three times in ice-cold saline by resuspension and centrifugation as above. The red cells were mixed with six volumes of ice-cold distilled water, left at 4°C for 10 minutes, and then centrifuged at 20 000 g for 30 minutes to produce the final haemolysate used in assays.
The aldolase C homotetramer has been successfully purified from guinea-pig" and rabbit" brains using a Results and discussion Fig.2 Isolation ofbrain aldolaseisoenyzmes by chromatography on cellulose phosphate. The column was run as described in Material and methods. Aldolase activity was assayed as described in the Material and methods section.
----% transmittance at 280nm; 0 -0 aldolase activity (IUlml).
PROPERTIES OF PURIFIED ALDOLASE C,
The final protein preparation appeared homogeneous 117 combination of affinity elution from cellulose phosphate, using the substrate FDP, and DEAE cellulose chromatography. However, the enzyme has not previously been purified from human brain. The purification procedure for the human brain enzyme is summarised in Fig. 1 ; the initial DEAE-cellulose step separated all five aldolase isoenzymes from more acidic proteins, and the latter accounted for approximately 25 % of the protein in the soluble brain extract. After ammonium sulphate precipitation, the five aldolase isoenzymes were selectively eluted from cellulose phosphate using a dilute solution of the substrate, FDP (Fig. 2) . Polyacrylamide gel electrophoresis, performed on the eluate from this column, showed that few contaminant proteins were eluted under the same conditions. The final stage in the purification involved the separation of aldolase C, from the other four isoenzymes by elution from DEAE-cellulose using a linear salt gradient (Fig. 3) . The results of a typical purification, using the lyophilised eluate from the first DEAE cellulose column as starting material, are shown in Table 1 . Between 4 and 6 mg of aldolase C, were obtained from a single purification, corresponding to between 30 and 40 mg per brain of 1Soo g wet weight. . . extract (1' 01. 4 ml) was run under the conditions described in the Material and methods section: 0 peak elution volumes of marker proteins; {', aldolase elution peak as assayed by catalytic activity; 0 aldolase elution peak as assayed by radioimmunoassay.
(I SS 000 ± IS 000). These results indicate that all five isoenzymes present in brain are of a similar molecular weight, and that no measurable changes in size occur during the purification procedure. The molecular weight of the aldolase C subunit, as determined by SDS gel electrophoresis, was found to be 41 SOO (Fig. Sb) . Both subunit and native molecular weights of the human brain aldolase C homotetramer thus appear to be close to those of 37 000 and 148 000 reported for the rabbit brain enzyme.to RADIOIMM UNOASSA Y Figure 6 shows the effect of the sheep anti-human aldolase C 4 antiserum on the enzyme activity of the purified protein ( Fig. 6a) and also on the binding of iodinated enzyme protein (Fig. 6b ). The binding curve (Fig. 6b) shows that the antiserum bound 50% of maximum counts at a dilution of 1 in 135 000 (in the initial antigen-antibody incubation). Figure 7 shows a typical standard curve for the radioimmunoassay; maximum sensitivity was approximately 500 5D .85A
'.8 pg per tube (ie 5 ngjml) and represented a displacement of 10% of the added tracer. The preincubation stage of the radioimmunoassay increased the sensitivity approximately 100fold, as shown in Figure 7 .
Immunoassay of the fractions obtained after separation of the five aldolase C-containing isoenzymes on DEAE cellulose (Fig. 3) showed that immunoreactivity was not confined to the aldolase C homotetramer, since all other C-containing isoenzymes caused reduction of counts bound to antibody in the assay. No immunoreactivity could be detected with the purified A 4 isoenzyme even with samples containing up to 500 ng total protein. Aldolos.e C in OSo'Sooy \ng\ 500 immunoreactivity associated with the AaC hybrid peak appeared to be considerably less than would be expected for the amount of enzyme activity present ( Fig. 3 ). As the specific activity of each form of the enzyme was similar (1' 3 IUfmg), this suggests that the single C subunit in the AaC tetramer is less immunologically active than in other hybrid forms. This could be due to steric hindrance by the A subunits, or possibly to the antiserum being largely specific for antigenic determinants lying in the bridge region between two C subunits. Dilution of a crude extract of human brain produced a curve of similar shape to that of the purified protein under the conditions of the immuno-",00 " 1 -.
Willson and Thompson assay (Fig. 8 ). This was also true of samples from each of the three purified A-C hybrids (Fig. 9) , providing further evidence of immunological similarity of aldolase C subunits in the hybrid and homotetramer forms.
LEVELS OF ALDOLASE C IN HUMAN TISS UES
Radioimmunoassay of human tissue extracts, prepared as described in the Material and methods section, produced the results shown in Table 2 . Immunoreactivity was present in most tissues examined but at levels less than 2 %of those seen in brain. Relatively high levels were seen in erythrocytes, adrenal gland, and liver, while immunoreactivity was virtually absent from the kidney and present at relatively low levels in ovary, skeletal muscle, and thyroid. Heart, which was the only human organ to show aldolase C apart from brain when examined electrophoretically,' contained less immunoreactive Human tissue extracts were prepared and assayed as described in the Material and methods section. The values given are the means of triplicate assays agreeing to within 10%.
Tissu~Aldolas« C. WIlIIl wet WI} Fig. 8 Comparison of radioimmunoassay standard curve using purified aldolase C~with dilutions of whole brain solubleprotein extract. The assay and dilutions of the brain extract were performed as described in the Material and methods section. The points shown are the means of duplicate determinations agreeing to within 10 %: 0--0 standard curve; e--e dilutions ofbrain extract. Fig. 9 Immunoreactivity of A-C hybrids in the aldolase C~radioimmunoassay. The radioimmunoassay was performed as described in the Material and methods section, using increasing dilutions of the A-C hybrid set obtained as in Fig. 3 . 0--0 standard curve;
6 --6 AaC; e--e AICI;
x--x AC.; 0----0 A1 aldolase C than small intestine, liver, adrenal, or erythrocytes. It was not possible to assay extracts of human pancreas since proteolytic activity breaks down the iodinated tracer and produces spuriously high levels of immunoreactivity in the radioimmunoassay. The cellular location of aldolase C in the brain is unknown; however, the existence of five-membered A-C hybrid sets has been taken to imply that the A and C subunits are contained within the same cell.' If the C subunit is contained within neurones rather than glia (as appears to be the case with another brain-specific isoenzyme, neurone-specific enolase),11 then at least some of the immunoreactivity found in other tissues could be accounted for by normal innervation. The presence of immunoreactivity in erythrocytes, however, demonstrates that the protein can occur in cells that have no nervous connections. The relatively high levels of aldolase C. contained in erythrocytes could possibly account for the low levels of immunoreactivity found, for example, in thyroid, lung, and skeletal muscle but are insufficient to account for the immunoreactivity found in heart, liver, or adrenal. It is of interest that a previous study on rabbit erythrocytes using electrophoresis and activity staining and also immunological inhibition of enzyme activityl! suggested that approximately 10 % of the total aldolase activity present was unaffected by anti-aldolase A and that A-C hybrid appeared to be present in rabbit haemolysates.
It is not known whether the low levels of aldolase C immunoreactivity found in tissues other than the brain represent enzymatically active protein. Furthermore, since hybrid forms of aldolase C appear immunologically identical with homotetramer, the immunoreactivity present in other tissues could be present in either a C. homotetramer or as A-C hybrid tetramers. B-C hybrid tetramers have not been detected electrophoretically.! The virtual absence of immunoreactivity in kidney extracts make it unlikely that such hybrids exist in human kidney; however, it is possible that some of the immunoreactivity present in human liver could be in this form.
The above results, which represent the first systematic immunological survey of human tissues for aldolase C, show that its presence is not unique to brain or innervated tissue. Although low levels of the protein (previously undetected by electrophoretic 121 methods) are present in most human tissues, the high degree of localisation of aldolase C in brain makes it a possible marker for damage to the central nervous system.
